• 免費註冊
  • 加入官方line@
  • 加入FB粉絲團

台股 » 個股 » 太景*-KY » 籌碼相關 » 券商分點績效 » 券商分點個股進出

太景*-KY

(4157)
可現股當沖
  • 股價
    10.80
  • 漲跌
    ▼0.05
  • 漲幅
    -0.46%
  • 成交量
    438張
  • 產業
    上櫃 生技醫療類股▲0.61%

  • 265人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
太景*-KY (4157)籌碼相關－兆豐-員林 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效，來找出真正獲利的贏家所在券商分點，進而追蹤此贏家所操作的股票與軌跡。

股票投資新手教室：一秒知道是否上對大戶列車

兆豐-員林 券商分點個股進出

兆豐-員林 券商分點全部個股操作績效/獲利分析

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/12/310.111.5000.0011.450.11,1140.01%
2024/12/26512.1000.0012.0051,1560.43%
2024/12/190.311.1500.0010.900.31,1110.02%
2024/12/110.111.8500.0011.850.11,1060.01%
2024/12/100.511.9500.0011.850.51,1100.05%
2024/12/09111.9000.0011.8511,1290.09%
2024/12/06212.0000.0012.0021,1220.18%
2024/11/27212.2000.0012.1021,1240.18%
2024/11/26512.2000.0012.3051,1330.44%
2024/11/205.312.4000.0012.455.39280.57%
2024/11/1900.00312.4512.55-3933-0.32%
2024/11/180.212.20212.3512.20-1.8965-0.18%
2024/11/15512.0000.0012.0059740.51%
2024/11/145.112.1600.0012.205.19320.55%
2024/11/120.413.4100.0013.250.48820.05%
2024/11/060.314.0000.0013.850.38930.03%
2024/10/290.114.0500.0013.950.11,0250.01%
2024/10/23514.2000.0014.1551,0350.48%
2024/10/22314.15114.1514.1521,0440.19%
2024/10/17214.3500.0014.3521,0910.18%
2024/10/11114.3500.0014.3011,1590.09%
2024/10/010.115.0500.0015.100.11,3230.01%
2024/09/1900.00314.5514.55-31,382-0.22%
2024/09/1800.00214.6514.55-21,398-0.14%
2024/09/12314.1500.0014.1531,4160.21%
2024/08/21214.5500.0014.4521,8370.11%
2024/08/20114.70214.8514.80-11,841-0.05%
2024/08/1900.001114.7114.70-111,819-0.60%
2024/08/1400.00114.5514.55-11,856-0.05%
2024/08/09114.50214.4014.30-11,914-0.05%
2024/08/08914.50414.0814.6051,9050.26%
2024/08/0700.00114.0014.05-11,896-0.05%
2024/08/05113.7500.0013.4511,9010.05%
2024/08/02214.0000.0014.0021,8400.11%
2024/07/29214.1500.0014.0521,9110.10%
2024/07/19114.3000.0014.3011,9790.05%
2024/07/170.114.7500.0014.750.12,0560.00%
2024/07/160.214.6200.0014.500.22,2490.01%
2024/07/1200.00214.8014.65-22,823-0.07%
2024/07/09414.5300.0014.6042,8240.14%
2024/07/08314.92915.0514.90-62,748-0.22%
2024/07/04115.0000.0015.0512,7030.04%
2024/07/0300.00215.1015.05-22,701-0.07%
2024/07/02115.0000.0015.0512,7010.04%
2024/07/0100.00415.2015.10-42,712-0.15%
2024/06/28215.2500.0015.1522,7040.07%
2024/06/1700.00115.2515.35-12,814-0.04%
2024/06/14315.0500.0015.0532,7920.11%
2024/06/11515.6300.0015.5552,7060.18%
2024/06/051015.3300.0015.40102,5760.39%
2024/06/0400.00515.2015.25-52,583-0.19%
2024/05/30115.15215.4515.35-12,621-0.04%
2024/05/2900.00115.1515.10-12,617-0.04%
2024/05/24414.90215.1015.0522,6170.08%
2024/05/2000.00115.8015.65-12,606-0.04%
2024/05/1700.00715.3915.55-72,580-0.27%
2024/05/13415.0800.0015.0542,5660.16%
2024/05/0900.001115.4415.35-112,540-0.43%
2024/05/08415.0000.0014.9542,4950.16%
2024/05/07114.8000.0014.8512,4930.04%
2024/05/06215.0000.0014.9522,4760.08%
2024/05/03815.0800.0015.0082,4780.32%
2024/04/303.215.53715.5115.35-3.82,429-0.16%
2024/04/259.115.57215.5015.507.12,3450.30%
2024/04/22516.301016.4815.60-52,247-0.22%
2024/04/193316.792516.5816.4582,0410.39%
2024/04/090.115.3000.0015.200.11,4330.01%
2024/04/03115.2500.0015.0511,4360.07%
2024/04/0100.00715.7015.70-71,403-0.50%
2024/03/291015.4500.0015.45101,3650.73%
2024/03/2800.001015.7015.45-101,349-0.74%
2024/03/261015.3500.0015.35101,2980.77%
2024/03/200.114.4500.0014.350.11,2380.00%
2024/03/120.115.1000.0014.900.11,2670.00%
2024/03/110.114.5500.0014.550.11,2460.00%
2024/03/0700.002014.4314.75-201,492-1.34%
2024/03/06014.9000.0014.7001,5690.00%
2024/02/2300.001315.2015.10-131,879-0.69%
2024/02/20015.5500.0015.5501,8370.00%
2024/02/191015.63315.7315.5071,8350.38%
太景抗流感病毒新藥 正式向中國藥監局申請上市許可UDN聯合新聞網－2024/08/04
太景*-KY（4157）4日晚間公告，接獲合作夥伴健康元藥業集團通知，太景開發的抗流感病毒新藥Pixavir (TG-1......詳全文
太景*-KY流感抗病毒新藥三期臨床 提前完成收案750人Anue鉅亨－2024/01/08
...詳全文
太景新藥 取得俄國藥證UDN聯合新聞網－2022/08/29
太景*-KY （4157）昨（28）日代子公司太景生技公告，抗生素新藥奈諾沙星靜脈輸液（500 mg/250 ml）已獲......詳全文
太景*-KY 相關文章